Get started
Author

Ulla‐Carin Tornberg

Observed names: U.C. Tornberg, Ulla-Carin Tornberg
Institution: BioInvent (Sweden)
ORCID: 0009-0009-6941-2437
Observed ORCID: 0009-0009-6941-2437
OpenAlex ID: A5027344574
B‐1a, B‐1b and B‐2 B cells display unique VHDJH repertoires formed at different stages of ontogeny and under different selection pressures.
1995 · U.C. Tornberg, D. Holmberg · The EMBO Journal · 98
V‐region directed selection in differentiating B lymphocytes.
1993 · F. Huetz, L. Carlsson, et al. · The EMBO Journal · 84
LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation
2020 · Muchaala Yeboah, Charys Papagregoriou, et al. · JCI Insight · 63
PDF
Deep Mining of Complex Antibody Phage Pools Generated by Cell Panning Enables Discovery of Rare Antibodies Binding New Targets and Epitopes
2019 · Anne Ljungars, Carolin Svensson, et al. · Frontiers in Pharmacology · 37
PDF
Regulation of B Lymphocyte Development by the Truncated Immunoglobulin Heavy Chain Protein Dμ
1998 · Ulla-Carin Tornberg, Ingela Bergqvist, et al. · The Journal of Experimental Medicine · 25
PDF
Rapid induction of apoptosis in B‐cell lymphoma by functionally isolated human antibodies
2006 · Johan Fransson, Ulla‐Carin Tornberg, et al. · International Journal of Cancer · 24
PDF
A bispecific IgG format containing four independent antigen binding sites
2020 · Anne Ljungars, Torbjörn Schiött, et al. · Scientific Reports · 12
PDF
Targeted disruption of the VH 81X gene: Influence on the B cell repertoire
1997 · François Huetz, Ulla‐Carin Tornberg, et al. · European Journal of Immunology · 7
Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al. · Cancer Research · 3
Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signaling
2026 · Hayden Fisher, Emma J. Sutton, et al. · Immunity · 1
A “Function-First” Approach to Identify Regulatory T cell–Targeting Antibodies for Immunotherapy
2025 · Kirstie L.S. Cleary, Monika Semmrich, et al. · Cancer Immunology Research · 1
PDF
Identity of IGHV-7183.1 ( V81x ) coding and recombination signal sequences among wild-derived mice
2001 · Stacy L. Hirano, Ulla-Carin Tornberg, et al. · Immunogenetics · 1
Supplementary Fig 1 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Fig 5 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Fig 4 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Table 1 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Data from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Fig 3 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Fig 10 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Fig 8 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Fig 9 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Fig 7 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Fig 2 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Fig 6 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Supplementary Materials and Methods from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
2026 · Linda Mårtensson, Petra Holmkvist, et al.
Works count: 35
Citation count: 356
H-index: 7
I10-index: 7
Year
Topic
Type